Traub Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Traub Capital Management's BMY Position: Q3 2026 in Review
Traub Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 15% in Q3 2026, selling an estimated $98K and leaving 8,678 shares worth $542K. The position accounts for 0.47% of the portfolio, ranked #50.
Traub Capital Management first reported a position in BMY in Q2 2025 and has held it in 6 quarters since. The position peaked at $620K in Q1 2026. 2,556 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Traub Capital Management held 8,678 shares of Bristol-Myers Squibb worth $542K as of Q3 2026.
- Traub Capital Management sold 1,550 Bristol-Myers Squibb shares in Q3 2026, an estimated $98K.
- Bristol-Myers Squibb made up 0.47% of Traub Capital Management's portfolio in Q3 2026, its #50 holding.
- Traub Capital Management first reported a position in Bristol-Myers Squibb in Q2 2025 and has held it in 6 quarters since.
- Traub Capital Management's Bristol-Myers Squibb position peaked at $620K in Q1 2026.
- 2,556 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Traub Capital Management's 13F filing for Q3 2026, filed 9 Nov 2026.